Oscar Health, Inc. (OSCR) Stock Forecast
Data as of Jun 16, 2026Healthcare · Current price $28.32 (-2.85%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 11, 2026 | Jonathan Yong | UBS | $15.00 | -47.0% |
| Jan 5, 2026 | Andrew Mok | Barclays | $18.00 | -36.4% |
| Aug 14, 2025 | Jessica Tassan | Piper Sandler | $13.00 | -54.1% |
| Aug 8, 2024 | Jessica Tassan | Piper Sandler | $28.00 | -1.1% |
| Jun 25, 2024 | Jessica Tassan | Piper Sandler | $25.00 | -11.7% |
| Jun 12, 2024 | Stephen Baxter | Wells Fargo | $27.00 | -4.7% |
| Jun 10, 2024 | Nathan Rich | Goldman Sachs | $21.00 | -25.8% |
| Mar 21, 2024 | John Ransom | Raymond James | $20.00 | -29.4% |
| Nov 15, 2022 | Stephen Baxter | Wells Fargo | $4.00 | -85.9% |
Top Analysts Covering OSCR
OSCR vs Sector & Market
| Metric | OSCR | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.88 | 2.24 | 2.40 |
| Analyst Count | 8 | 8 | 19 |
| Target Upside | -22.7% | +11475.1% | +17.1% |
| P/E Ratio | -11.53 | 3.92 | 31.64 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $18.72B | $18.78B | $18.84B | 6 |
| 2027-03-31 | $4.86B | $4.97B | $5.05B | 2 |
| 2027-06-30 | $4.93B | $5.04B | $5.13B | 2 |
| 2027-09-30 | $4.89B | $5.00B | $5.09B | 2 |
| 2027-12-31 | $4.72B | $4.82B | $4.91B | 2 |
| 2028-03-31 | $5.16B | $5.27B | $5.36B | 1 |
| 2028-06-30 | $5.75B | $5.87B | $5.98B | 1 |
| 2028-09-30 | $5.74B | $5.86B | $5.97B | 1 |
| 2028-12-31 | $5.52B | $5.64B | $5.74B | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-1.90 | $0.60 | $2.23 | 6 |
| 2027-03-31 | $1.39 | $1.43 | $1.46 | 2 |
| 2027-06-30 | $0.38 | $0.39 | $0.40 | 1 |
| 2027-09-30 | $0.17 | $0.17 | $0.17 | 1 |
| 2027-12-31 | $-0.73 | $-0.72 | $-0.70 | 2 |
| 2028-03-31 | $1.77 | $1.82 | $1.86 | 3 |
| 2028-06-30 | $0.68 | $0.70 | $0.72 | 2 |
| 2028-09-30 | $0.33 | $0.33 | $0.34 | 2 |
| 2028-12-31 | $-0.77 | $-0.76 | $-0.74 | 3 |
Frequently Asked Questions
What is the analyst consensus for OSCR?
The consensus among 8 analysts covering Oscar Health, Inc. (OSCR) is Hold with an average price target of $16.75.
What is the highest price target for OSCR?
The highest price target for OSCR is $28.00, set by Jessica Tassan at Piper Sandler on 2024-08-08.
What is the lowest price target for OSCR?
The lowest price target for OSCR is $4.00, set by Stephen Baxter at Wells Fargo on 2022-11-15.
How many analysts cover OSCR?
8 analysts have issued ratings for Oscar Health, Inc. in the past 12 months.
Is OSCR a buy or sell right now?
Based on 8 analyst ratings, OSCR has a consensus rating of Hold (2.88/5) with a -22.7% upside to the consensus target of $16.75.
What are the earnings estimates for OSCR?
Analysts estimate OSCR will report EPS of $0.60 for the period ending 2026-12-31, with revenue estimated at $18.78B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.